癌症免疫治疗挑战来自自-免疫检查点相互调节
Gang Zhang1, Yinfeng Chen1, Xing Huang1
1Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang, China; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China; Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou 310003, Zhejiang, China; The Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou 310009, Zhejiang, China; Cancer Center, Zhejiang University, Hangzhou 310058, Zhejiang, China.
将自性向疗法与免疫检查点抑制剂 (ICI) 结合起来,在癌症治疗方面表现有前途. 了解自和ICI之间的复杂相互作用对于优化治疗策略和改善患者治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 免疫检查点抑制剂 (ICI) 是现代癌症治疗的基石.
- 结合策略被用来提高ICI的疗效,但往往面临局限性.
- 自调节是一种改善ICI治疗结果的潜在策略.
研究的目的:
- 审查自和免疫检查点之间的相互相互作用.
- 探索将自性向治疗与ICI结合的优势.
- 为优化组合治疗方案提供指导方针.
主要方法:
- 临床前和临床研究的文献综述.
- 对调节自和免疫检查点的分子机制的分析.
- 综合关于组合疗法的当前证据.
主要成果:
- 自调节可以增强瘤免疫性,减少ICI的副作用.
- 自和免疫检查点之间存在复杂的相互调节网络.
- 目前的组合策略有局限性,需要解决.
结论:
- 与ICI一起准自为更广泛的患者群体提供潜在的好处.
- 需要进一步的研究来阐明自和免疫检查点之间的复杂关系.
- 精心确定和调整治疗方案对于成功的组合疗法至关重要.
相关概念视频
Tumor Immunotherapy
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Intrinsic Apoptotic Pathway
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...


